Lysine Acetyltransferase 5: Clinical Trials

5 trials of Lysine Acetyltransferase 5, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 3 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1
Phase 21Completed 1
Phase 41Terminated 1

Follow Lysine Acetyltransferase 5: new trials by email Literature Review of Lysine Acetyltransferase 5 trials Research Report on Lysine Acetyltransferase 5

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Is Dorsal Inlay Graft (DIG) With TIP Repair Superior to TIP Alone for Primary Hypospadias?
Repaired with standard TIP repair as described by Snodgrass, Repaired with TIP with GIP using preputial graft - Hypospadias
Not applicableRecruitingMohammad Daboos5842023-01-022025-07-25
Evaluation of TIP Urethroplasty With Spongioplasty-Dartosoraphy Reinforcement in Pediatric Hypospadias
Tubularized Incised Plate (TIP) urethroplasty - Hypospadias, Complication,Postoperative
Not applicableCompletedAl-Azhar University2202019-04-012023-07-25
Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection
TIP, TIP and placebo, Placebo - Non-cystic Fibrosis Bronchiectasis
Phase 2CompletedNovartis Pharmaceuticals1072017-02-082020-08-25
Patient-Centred Innovations for Persons With Multimorbidity - Ontario
TIP / IMPACT Plus Care Coordination - Hypertension, Depression
Not applicableCompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1752016-01-122023-03-17
Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa
TIS or TIP - Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis
Phase 4TerminatedNovartis Pharmaceuticals172015-01-272018-10-09

Conditions studied

Hypospadias (2)  ·  Alzheimer Disease (1)  ·  Anxiety Disorders (1)  ·  Arthritis (1)  ·  Arthritis, Rheumatoid (1)  ·  Asthma (1)  ·  Bronchiectasis (1)  ·  Bronchitis, Chronic (1)  ·  Cardiovascular Diseases (1)  ·  Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  Cystic Fibrosis (1)  ·  Dementia (1)  ·  Depression (1)  ·  Diabetes Mellitus (1)

Sponsors

Novartis Pharmaceuticals (2)  ·  Al-Azhar University (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Mohammad Daboos (1)

Countries

Egypt (2)  ·  Germany (2)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Mohammad Daboos (1)  ·  Moira Stewart (1)

Results publications

PMID 28487349, PMID 31433997, PMID 32532226, PMID 32855225, PMID 41588344

NIH funding

2015 (1)